These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 358445)

  • 41. High-performance liquid chromatography and picomole-level detection of peptides and proteins.
    Stein S; Moschera J
    Methods Enzymol; 1981; 79(Pt B):7-16. PubMed ID: 6173724
    [No Abstract]   [Full Text] [Related]  

  • 42. Large-scale production of human fibroblast interferon.
    Van Damme J; Billiau A
    Methods Enzymol; 1981; 78(Pt A):101-19. PubMed ID: 6173574
    [No Abstract]   [Full Text] [Related]  

  • 43. [Estimation of the molecular weight of the interferon produced by human leukocytes].
    Falcoff E; Lévy H; Colin J; Chany C
    C R Acad Hebd Seances Acad Sci D; 1965 May; 260(20):5405-7. PubMed ID: 4954007
    [No Abstract]   [Full Text] [Related]  

  • 44. [Comparative immunochemical and physico-chemical studies of the system of human soluble leukocyte antigens].
    Petrunin DD; Lopukhin IuM
    Gematol Transfuziol; 1985 Nov; 30(11):3-7. PubMed ID: 4085768
    [No Abstract]   [Full Text] [Related]  

  • 45. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 46. Procedures for stabilization of interferons.
    Sedmak JJ; Jameson P; Grossberg SE
    Methods Enzymol; 1981; 78(Pt A):591-5. PubMed ID: 6173648
    [No Abstract]   [Full Text] [Related]  

  • 47. Radiation inactivation and target size analysis of interferons.
    Kempner ES; Pestka S
    Methods Enzymol; 1986; 119():255-60. PubMed ID: 3093803
    [No Abstract]   [Full Text] [Related]  

  • 48. Definition and classification of the interferons.
    Pestka S; Baron S
    Methods Enzymol; 1981; 78(Pt A):3-14. PubMed ID: 6173606
    [No Abstract]   [Full Text] [Related]  

  • 49. INTERFERON: A CELLULAR PRODUCT WHICH INHIBITS VIRUSES.
    PAUCKER K
    Clin Pediatr (Phila); 1964 Nov; 3():671-8. PubMed ID: 14218971
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular alterations of interferons.
    Stewart WE; Lin L; Chudzio T; Wiranowska-Stewart M
    Tex Rep Biol Med; 1977; 35():193-7. PubMed ID: 358448
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Purification and physico-chemical properties of interferons].
    Kolaczkowska MK
    Postepy Hig Med Dosw; 1974 Mar; 28(2):229-42. PubMed ID: 4840972
    [No Abstract]   [Full Text] [Related]  

  • 52. [Purification and molecular properties of interferon (author's transl)].
    Kawade Y; Yamamoto Y
    Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):287-95. PubMed ID: 13463
    [No Abstract]   [Full Text] [Related]  

  • 53. Purification of murine interferon.
    Kawade Y
    Tex Rep Biol Med; 1977; 35():181-6. PubMed ID: 358446
    [No Abstract]   [Full Text] [Related]  

  • 54. Interferons: chemical properties.
    Fantes KH
    Tex Rep Biol Med; 1977; 35():173-80. PubMed ID: 358445
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.